Q2 2023 Holdings
Filed 2023-08-14 | 70 holdings | $286.3M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-08-21) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $4.9M | 300,000 | 1.7% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $4.9M | 260,000 | 1.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $5.2M | 57,760 | 1.8% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $5.4M | 650,875 | 1.9% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $5.6M | 900,723 | 1.9% |
| Viking Therapeutics Inc(VKTX)Put | COM | 92686J106 | $5.7M | 350,000 | 2.0% |
| Bridgebio Pharma Inc(BBIO)Put | COM | 10806X102 | $6.5M | 376,000 | 2.3% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $6.8M | 100,000 | 2.4% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $7.2M | 226,275 | 2.5% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $9.5M | $12,000,000 | 3.3% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $9.5M | 447,667 | 3.3% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $9.6M | 910,317 | 3.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $11.4M | 40,000 | 4.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $11.5M | 1,050,118 | 4.0% |
| Morphic Hldg Inc | COM | 61775R105 | $11.6M | 201,887 | 4.0% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $12.0M | 1,600,000 | 4.2% |
| Madrigal Pharmaceuticals Inc(MDGL)Call | COM | 558868105 | $12.3M | 53,100 | 4.3% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $12.3M | 321,017 | 4.3% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $14.5M | 211,608 | 5.1% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $17.5M | 550,000 | 6.1% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $21.4M | 92,500 | 7.5% |